Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Broder

Showing results (241-250 of 451) with videos related to

Pageof 46
Sort By:
Science (New York, N.Y.)|March 23, 1984
Transformation and cytopathogenic effect in an immune human T-cell clone infected by HTLV-IH Mitsuya, H G Guo, M Megson, et al.
AIDS (London, England)|February 1, 1989
T-cell response towards HIV in infected individuals with and without zidovudine therapy, and in HIV-exposed sexual partnersA Ranki, S Mattinen, R Yarchoan, et al.
Oncology|March 7, 2018
Real-World Treatment Patterns for Lung Neuroendocrine Tumors: A Claims Database AnalysisMichael S Broder, Beilei Cai, Eunice Chang, et al.
Clinical Obstetrics and Gynecology|May 22, 2007
Ovarian conservation at the time of hysterectomy for benign diseaseWilliam H Parker, Michael S Broder, Zhimei Liu, et al.
Menopause (New York, N.Y.)|May 4, 2007
Elective oophorectomy for benign gynecological disordersDonna Shoupe, William H Parker, Michael S Broder, et al.
Climacteric : the Journal of the International Menopause Society|September 27, 2006
Response to commentaries on retention of the ovaries and long-term survival after hysterectomyW H Parker, M S Broder, Z Liu, et al.
Journal of Medicinal Chemistry|August 1, 1987
3'-substituted 2',3'-dideoxynucleoside analogues as potential anti-HIV (HTLV-III/LAV) agentsP Herdewijn, J Balzarini, E De Clercq, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1980
High molecular weight antigens present on human T cellsW Judd, C A Poodry, S Broder, et al.
American Health & Drug Benefits|December 21, 2020
Economic Burden of Neurologic Toxicities Associated with Treatment of Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma in the United StatesMichael S Broder, Qiufei Ma, Tingjian Yan, et al.
The American Journal of Managed Care|August 9, 2011
Cost-effectiveness of 21-gene assay in node-positive, early-stage breast cancerBurton F Vanderlaan, Michael S Broder, Eunice Y Chang, et al.
Pageof 46

Showing results (241-250 of 451) with videos related to

Sort By:
Pageof 46
Science (New York, N.Y.)|March 23, 1984
Transformation and cytopathogenic effect in an immune human T-cell clone infected by HTLV-IH Mitsuya, H G Guo, M Megson, et al.
AIDS (London, England)|February 1, 1989
T-cell response towards HIV in infected individuals with and without zidovudine therapy, and in HIV-exposed sexual partnersA Ranki, S Mattinen, R Yarchoan, et al.
Oncology|March 7, 2018
Real-World Treatment Patterns for Lung Neuroendocrine Tumors: A Claims Database AnalysisMichael S Broder, Beilei Cai, Eunice Chang, et al.
Clinical Obstetrics and Gynecology|May 22, 2007
Ovarian conservation at the time of hysterectomy for benign diseaseWilliam H Parker, Michael S Broder, Zhimei Liu, et al.
Menopause (New York, N.Y.)|May 4, 2007
Elective oophorectomy for benign gynecological disordersDonna Shoupe, William H Parker, Michael S Broder, et al.
Climacteric : the Journal of the International Menopause Society|September 27, 2006
Response to commentaries on retention of the ovaries and long-term survival after hysterectomyW H Parker, M S Broder, Z Liu, et al.
Journal of Medicinal Chemistry|August 1, 1987
3'-substituted 2',3'-dideoxynucleoside analogues as potential anti-HIV (HTLV-III/LAV) agentsP Herdewijn, J Balzarini, E De Clercq, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1980
High molecular weight antigens present on human T cellsW Judd, C A Poodry, S Broder, et al.
American Health & Drug Benefits|December 21, 2020
Economic Burden of Neurologic Toxicities Associated with Treatment of Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma in the United StatesMichael S Broder, Qiufei Ma, Tingjian Yan, et al.
The American Journal of Managed Care|August 9, 2011
Cost-effectiveness of 21-gene assay in node-positive, early-stage breast cancerBurton F Vanderlaan, Michael S Broder, Eunice Y Chang, et al.
Pageof 46